European Medicines Agency's workshop on nanomedicines

Event Medicines

Date: Thursday, 2 September 2010, All day
Location: European Medicines Agency, Amsterdam, the Netherlands

On 2-3 September 2010, EMA hosted the first international scientific workshop on nanomedicines. Some 200 European and international participants from 27 countries including Australia, Canada, India, Japan and the United States discussed benefits and challenges arising from the application of nanotechnologies to medicines. Participants included representatives from patients' organisations, health care professionals' organisations, academia, regulatory authorities and pharmaceutical industry.

Documents

Summary report - Workshop on nanomedicines: 2-3 September 2010

Reference Number: EMA/538503/2010 Summary:

On 2-3 September 2010, the European Medicines Agency (EMA) hosted the first international scientific

workshop on nanomedicines. Some 200 European and international participants from 27 countries

including Australia, Canada, India, Japan and the United States discussed the benefits and challenges

arising from the application of nanotechnologies to medicines. Participants included representatives

from patients’ organisations, health care professionals’ organisations, academia, regulatory authorities

and pharmaceutical industry.

English (EN) (3.74 MB - PDF)

First published: 22/10/2010 Last updated: 22/10/2010

Agenda - Workshop on nanomedicines: 2-3 September 2010

Reference Number: EMA/273690/2010

English (EN) (173.17 KB - PDF)

First published: 15/03/2010 Last updated: 09/09/2010

Presentation - Workshop on nanomedicines - Introduction, Patrick le Courtois, EMA

English (EN) (483.14 KB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Keynote lecture - Key ongoing applications in nanosciences and how they apply to pharmaceuticals, Rutledge Ellis-Behnke, MIT

English (EN) (38.7 MB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Engineering nanoparticles for biomedical applications, Mamoun Muhammed, Royal Institute of Technology, Stockholm

English (EN) (5.49 MB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Special aspects of nanomedicines: development, manufacturing and characterisation, Simon Holland, GlaxoSmithKline

English (EN) (1.11 MB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Special aspects of nanomedicines: Viewpoint from the industry, Jan Mà¶schwitzer, Abbott Healthcare Products B.V.

English (EN) (5.58 MB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Immunology and immunotoxicity of nanomedicines, Jacques Descotes, Lyon University Hospitals, France

English (EN) (193.45 KB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Nanotechnology - What about safety? How do we determine risk? Wim H de Jong, National Institute for Public Health and the Environment, Bilthoven

English (EN) (2.02 MB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Nanomedicines interaction with biological systems, Kenneth Dawson, University College of Dublin

English (EN) (5.14 MB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Nanomedicines on the market and in clinical development - Introduction, Eric Abadie, CHMP chair

English (EN) (751.58 KB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Liposomal nanomedicines and innovative formulations, Daan Crommelin, Utrecht University

English (EN) (1.64 MB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Polymer conjugates, Ruth Duncan, Cardiff University

English (EN) (11.72 MB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Nanoparticles, Rogà©rio Gaspar, University of Lisbon

English (EN) (4.31 MB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Novel and innovative nanotechnology-based delivery systems, Alexander Kabanov, University of Nebraska Medical Center

English (EN) (7.28 MB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Nanosystems in regenerative medicine, Jà¶ns Hilborn, Uppsala University

English (EN) (6.35 MB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Theranostics nanoparticles, Peter Dobson, Oxford University

English (EN) (2.69 MB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Safety specification - Identification and methodologies, Annalisa Rubino, EMA

English (EN) (465.75 KB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Pharmacovigilance and risk minimisation plans, Jan Petracek, PharmInvent

English (EN) (1.12 MB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Specific methodological issues and implications for risk assessment, Silvia Berkner, German Federal Environmental Agency

English (EN) (2.5 MB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Nanomedicines - Current initiatives in the US, Carlos Peà±a, FDA

English (EN) (164.16 KB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Nanomedicines - Current initiatives in Japan, Kumiko Sakai-Kato, Toru Kawanishi, National Institute of Health Sciences/MHLW

English (EN) (376.02 KB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Nanomedicines - Current initiatives in Canada, Duc Vu, Health Canada

English (EN) (372.3 KB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Presentation - Way forward, Marisa Papaluca, EMA

English (EN) (392.09 KB - PDF)

First published: 09/09/2010 Last updated: 09/09/2010

Multimedia